Status:
COMPLETED
Contribution of Hypnosis to Anxiety and Pain in Brachytherapy Patients
Lead Sponsor:
Institut de Cancérologie de Lorraine
Conditions:
Cancer
Brachytherapy
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
Formal hypnosis is a non-drug technique known to decrease anxiety and pain during the preoperative procedure. In brachytherapy, the practice of hypnosis has been shown to be feasible and beneficial f...
Eligibility Criteria
Inclusion
- Adult patients ≥ 18 and ≤ 80 years
- Patients expected to benefit a brachytherapy detachment Under KALINOX® for one of the types of applications described below:
- Deep interstitial application: anal canal, vagina, vulva
- Gynecological application: mold, Utrecht® system or Venezia® system
- Ability to provide written informed consent
- Patients affiliated to the social security system
Exclusion
- Minor and patients over 80 years old
- Patients with major hearing loss
- Patients who had recent ocular surgery with oculiare gas injection.
- Patients suffering from psychotic disorders, and dementias.
- Patients who do not understand the French language
- Patients under guardianship or deprived of liberty
- Patients with a contraindication to the administration of KALINOX®
Key Trial Info
Start Date :
November 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 25 2022
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT03755895
Start Date
November 2 2019
End Date
May 25 2022
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, France, 54519